N
Neal L. Benowitz
Researcher at University of California, San Francisco
Publications - 825
Citations - 66786
Neal L. Benowitz is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Nicotine & Cotinine. The author has an hindex of 126, co-authored 792 publications receiving 60658 citations. Previous affiliations of Neal L. Benowitz include Shaare Zedek Medical Center & University College London.
Papers
More filters
Journal ArticleDOI
Saliva cotinine levels as a function of collection method
Nina G. Schneider,Nina G. Schneider,Peyton Jacob,Fredrik Nilsson,Scott J. Leischow,Neal L. Benowitz,Richard G. Olmstead +6 more
TL;DR: It is postulated that changes in salivary flow can account for the findings and it is proposed that changesInSaliva cotinine intake can be changed to estimate nicotine intake using different methods of collection.
Journal ArticleDOI
Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking
Rachel F. Tyndale,Andy Z. X. Zhu,Tony P. George,Paul M. Cinciripini,Larry W. Hawk,Robert A. Schnoll,Gary E. Swan,Neal L. Benowitz,Daniel F. Heitjan,Caryn Lerman +9 more
TL;DR: The data suggest that CHRNA5-A3-B4 gene variants do not exhibit a robust association with smoking cessation and are unlikely to be useful for clinically optimizing smoking cessation pharmacotherapy for Caucasian smokers.
Journal ArticleDOI
Methadone-disulfiram interaction during methadone maintenance.
TL;DR: It was shown that in doses used for management of alcoholism there was no significant interaction between disulfiram and methadone, and this suggests enhanced N-demethylation during disulfIRam treatment.
Journal ArticleDOI
Pharmacogenetics of nicotine metabolism in twins: Methods and procedures
Gary E. Swan,Neal L. Benowitz,Peyton Jacob,Christina N. Lessov,Rachel F. Tyndale,Kirk C. Wilhelmsen,Ruth Krasnow,Mary McElroy,Sharyn E. Moore,Michelle Wambach +9 more
TL;DR: The approach taken, with its use of a quantitative model of nicotine metabolism, highly refined metabolic phenotypes, measured genotype, and advanced tools for biometric genetic analysis, provides a model for the use of twins in next-generation studies of complex drug-metabolism phenotypes.
Journal ArticleDOI
Cytisine, the world’s oldest smoking cessation aid
TL;DR: There is growing evidence for its use as an affordable treatment globally and calls for more research to be made into its safe and effective use in clinical practice.